HIV prevention

New PrEP Study Shows Significant Results for HIV Prevention

New PrEP Study Shows Significant Results for HIV Prevention

Researchers from the HIV Prevention Trials Network (HPTN) announced today that the HPTN 083 clinical trial showed that a pre-exposure prophylaxis (PrEP) regimen containing long-acting cabotegravir (CAB LA) injected once every eight weeks was superior to daily oral...
1 2 3 14
X